Search by Drug Name or NDC
NDC 68462-0208-01 Moexipril Hydrochloride 15 mg/1 Details
Moexipril Hydrochloride 15 mg/1
Moexipril Hydrochloride is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., USA. The primary component is MOEXIPRIL HYDROCHLORIDE.
MedlinePlus Drug Summary
Moexipril is used to treat high blood pressure. Moexipril is in a class of medications called angiotensin-converting enzyme (ACE) inhibitors. It decreases certain chemicals that tighten the blood vessels, so blood flows more smoothly and the heart can pump blood more efficiently. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 68462-0208-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Moexipril
Product Information
| NDC | 68462-0208 |
|---|---|
| Product ID | 68462-208_4ed36996-d19e-470c-91d6-a296ea64b753 |
| Associated GPIs | 36100033100320 |
| GCN Sequence Number | 023592 |
| GCN Sequence Number Description | moexipril HCl TABLET 15 MG ORAL |
| HIC3 | A4D |
| HIC3 Description | ANTIHYPERTENSIVES, ACE INHIBITORS |
| GCN | 48562 |
| HICL Sequence Number | 009934 |
| HICL Sequence Number Description | MOEXIPRIL HCL |
| Brand/Generic | Generic |
| Proprietary Name | Moexipril Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Moexipril Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 15 |
| Active Ingredient Units | mg/1 |
| Substance Name | MOEXIPRIL HYDROCHLORIDE |
| Labeler Name | Glenmark Pharmaceuticals Inc., USA |
| Pharmaceutical Class | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA090416 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 68462-0208-01 (68462020801)
| NDC Package Code | 68462-208-01 |
|---|---|
| Billing NDC | 68462020801 |
| Package | 100 TABLET, FILM COATED in 1 BOTTLE (68462-208-01) |
| Marketing Start Date | 2010-12-31 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.8792 |
| Pricing Unit | EA |
| Effective Date | 2023-12-20 |
| NDC Description | MOEXIPRIL HCL 15 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |